Paradigm Biopharmaceutic...【PAR】銘柄情報 | ADVFN

US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
オーストラリア
ASX
Paradigm Biopharmaceuticals Ltd (PAR) 銘柄情報

Paradigm Biopharmaceuticals Ltd (PAR)

0.275

0.03

(12.24%)

終了 11月20日 2:00PM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.275

買値

0.275

売値

0.28

出来高

2,166,743

0.24 日の範囲 0.28

0.165 52 週間の範囲 0.48

時価総額

前日終値

0.245

始値

0.245

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

1,111,228

発行済株式数

349,795,939

配当利回り

-

PER

-1.61

1 株当たり利益 (EPS)

-0.17

歳入

6.11M

純利益

-58.65M

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.paradigmbiopharma.com

本社

Melbourne, Victoria, Aus

設立

-

Paradigm Biopharmaceuticals Ltd is listed in the Pharmaceutical Preparations sector of the オーストラリア証券取引所 with ticker PAR. The last closing price for Paradigm Biopharmaceutic... was AUD0.25. Over the last year, Paradigm Biopharmaceutic... shares have traded in a share price range of AUD 0.165 to AUD 0.48.

Paradigm Biopharmaceutic... currently has 349,795,939 shares in issue. The market capitalisation of Paradigm Biopharmaceutic... is AUD85.70 million. Paradigm Biopharmaceutic... has a price to earnings ratio (PE ratio) of -1.61.

No news to show yet.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.055	25	0.22	0.28	0.22	634852	0.23570624	DE
4	0.045	19.5652173913	0.23	0.28	0.195	1028103	0.21459982	DE
12	0.04	17.0212765957	0.235	0.29	0.165	1111228	0.21771845	DE
26	-0.015	-5.1724137931	0.29	0.315	0.165	790583	0.22942549	DE
52	-0.125	-31.25	0.4	0.48	0.165	734071	0.28734132	DE
156	-1.945	-87.6126126126	2.22	2.3	0.165	659103	0.80841911	DE
260	-3.185	-92.0520231214	3.46	4.5	0.165	855388	1.78494095	DE

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
AZLOArizona Lithium Ltd	AUD 0.002 (100.00%)	20k
CR9OCorella Resources Ltd	AUD 0.002 (100.00%)	428.52k
AXPAXP Energy Limited	AUD 0.0015 (50.00%)	5.15M
EELENRG Elements Ltd	AUD 0.0015 (50.00%)	56.54k
CR9Corella Resources Limited	AUD 0.006 (50.00%)	1.43M
TVNOTivan Ltd	AUD 0.007 (-46.15%)	10k
NRZNeuRizer Ltd	AUD 0.002 (-42.86%)	13.38M
ADXADX Energy Limited	AUD 0.06 (-40.00%)	3.96M
EXTODExcite Technology Services Ltd	AUD 0.002 (-33.33%)	500k
MTBMount Burgess Mining Nl	AUD 0.001 (-33.33%)	774.78k
1TTThrive Tribe Technologies Ltd	AUD 0.004 (33.33%)	58.69M
PENPeninsula Energy Ltd	AUD 0.0565 (-9.60%)	57.61M
88E88 Energy Limited	AUD 0.0015 (0.00%)	51.31M
RSGResolute Mining Limited	AUD 0.425 (1.19%)	45.18M
DVLDorsaVi Ltd	AUD 0.015 (15.38%)	39.53M

HoldEm777

HoldEm777 5分前

T3 bid says they want to drop it.

mzasif

$BNCM .03 wow! 10Q results $8m in revenue, 97m in assets, 10m in float and 499m in O/S

IronChefQuezon

IronChefQuezon 5分前

Maria56

Maria56 5分前

So who holds Richard Lapoutre's shares now?

dstock07734

dstock07734 5分前

DD,

Truly amazing investigation! They should sticky this one. But I doubt they would.

Great honor to have you as a great comrade!

csuck555

csuck555 5分前

Everyone needs to do their part and tell the world about this gem before it's too late to get on board. Post about it on message boards. Mention it on social media. Comment about it on YouTube. Do something.

toncatmad

toncatmad 5分前

Leave it to Dugar to make Yoga pants carbon negative.
Still doesn't change the fact that FKA BioAmber shareholders lost their investment due to its liquidation back in 2018 but hey who doesn't love yoga pants.

Cward16

Cward16 5分前

JV44

Eventually yes. 🫡

peafunke

peafunke 6分前

Guess no yield just yet. Maybe today he releases the filing ? The calculator did say yesterday but wondering if better and day delayed it by a day. Not sure

TheKid5

TheKid5 6分前

All further reports will show continuous improvements. More funding news coming. The future is bright

georgie18

georgie18 6分前

GNPX...$1.27...NEWS...🥳...https://www.prnewswire.com/news-releases/genprex-signs-exclusive-license-to-additional-gene-therapy-technologies-with-the-university-of-michigan-for-the-treatment-of-lung-cancer-302311506.html

Monksdream

Monksdream 6分前

Canna_Business

Canna_Business 6分前

The Maryland Department of Agriculture allows the use of neem oil on medical cannabis during the flowering phase, but this raises significant health and safety concerns. Neem oil, while widely recognized as an organic pesticide, can transform into hazardous compounds when exposed to high heat, such

1vman

***** No !!! 🚽UBQU🚽 Does not have 5 million in revenues , point in fact financials are not very good

ENOUGH SAID HUZZAH🤪 !!!

varjim

https://www.otcmarkets.com/otcapi/company/financial-report/417149/content

katiesdad7

katiesdad7 6分前

Someone dumping early. Still 20K on the ask. Not a good sign.

stealofadeal

stealofadeal 6分前

$GEVI We opened up strong here. Something is brewing!

TheHappyVulcan

TheHappyVulcan 6分前

Ah, yes. Shoot the messenger. I am an easy target. All I did here was to report facts. No fiction. Everyone who vetted Astra and HES prior to making the cash committment must all have been completely fooled at every turn .

Just as rich as calling the HES technology an over

rdeano221

rdeano221 6分前

Halted up ! Yahoo!!

georgie18

georgie18 6分前

GNPX...$1.27...NEWS...🥳...https://www.prnewswire.com/news-releases/genprex-signs-exclusive-license-to-additional-gene-therapy-technologies-with-the-university-of-michigan-for-the-treatment-of-lung-cancer-302311506.html

linkvest

linkvest 6分前

RADR ... This stock should be in your portfolio... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175407637

Canna_Business

Canna_Business 7分前

The Maryland Department of Agriculture allows the use of neem oil on medical cannabis during the flowering phase, but this raises significant health and safety concerns. Neem oil, while widely recognized as an organic pesticide, can transform into hazardous compounds when exposed to high heat, such

TerraRyzing

TerraRyzing 7分前

Well it is Pink Current again, so....

georgie18

georgie18 7分前

GNPX...$1.27...NEWS...🥳...https://www.prnewswire.com/news-releases/genprex-signs-exclusive-license-to-additional-gene-therapy-technologies-with-the-university-of-michigan-for-the-treatment-of-lung-cancer-302311506.html

Paradigm Biopharmaceutic...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約